← All trials
NCT05852041
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 7, 2023
- Primary completion
- Jun 7, 2027
- Completion date
- Jun 7, 2035
- First posted
- May 10, 2023
- Last posted
- Oct 3, 2023
- Enrollment
- 40
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Northwestern UniversityLead sponsor
- National Cancer Institute (NCI)Collaborator
- Northwestern UniversityOverall official - principal investigator
- Northwestern UniversityReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.